IVF Genetic Risk Scoring Market, By Test Type (Polygenic Risk Scoring, Whole Genome Sequencing, Carrier Screening Panels and Single-Gene Risk Scoring), By Technology, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6132
|
Published Date
September 2026
|
Pages
345
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
IVF Genetic Risk Scoring market size was valued at US$ 380.2 Million in 2025, expanding at a CAGR of 13.3% from 2026 to 2033.
IVF genetic risk scoring refers to a new reproductive genomic application that is based on scores that add up the collective individual genetic predispositions from embryonic DNA in order to rank the embryos in a series of embryos for their risk of suffering from diseases during their lifetime (and not just whether the embryo has the correct amount of DNA). The technology workflow involves first the isolation of trophectoderm cells, the amplification of the DNA of these cells, and the genotyping of the whole genome, followed by the submission of the data of these DNA variations into the computation process, where these variations will be matched with the genetic risks of GWAS large databases and produce a risk percentile for each embryo. This approach enhances embryo selection by integrating genetic insights into personalized reproductive care.
IVF Genetic Risk Scoring Market- Market Dynamics
Advancements in Reproductive Technologies to Drive Market Growth
Advancements in reproductive technologies are driving the IVF Genetic Risk Scoring market due to the emergence of new technologies in genetic testing and embryo screening that facilitate the early detection of genetic risks before transferring the embryos. For instance, according to the data provided by the UK Human Fertilisation and Embryology Authority (Gov) in June 2026, there were 53,000 people undergoing treatment at licensed fertility clinics in the UK, of which 48% of total IVF treatments were frozen embryo transfers, indicating how popular these procedures have become. The birth rate per embryo transfer was estimated at 30%, which is 20% higher compared to last year\'s 38% birth rate. This success was observed among patients aged 18-34 years.
Moreover, the number of egg freezing procedures increased dramatically to 5,580 compared to last year\'s 700 procedures, while embryo freezing procedures grew from 1,900 last year to 10,450 procedures in 2026. These advancements are accelerating the adoption of genetic screening in IVF and improving reproductive outcomes.
IVF Genetic Risk Scoring Market- Segmentation Analysis:
The Global IVF Genetic Risk Scoring market is segmented on the basis of Test Type, Technology, Application, End User, and Region.
In terms of test type, polygenic risk scoring holds a substantial share in the IVF Genetic Risk Scoring market as a result of its application in the determination of the risk of common complex diseases in an embryo’s genetic makeup that helps to select the right embryos for the process of in vitro fertilisation. In April 2026, Juno Genetics researchers were involved in a research paper that sought to model the effectiveness and limitations of polygenic embryo screening among real-world IVF patients. This growing adoption highlights the increasing role of polygenic scoring in evidence-based embryo selection.
The NGS (Next-Generation Sequencing) segment holds a prominent share in the IVF Genetic Risk Scoring market because of its varied usages in assessing gene variability and screening advanced embryos at risk. For instance, in April 2026, a retrospective cohort analysis at Poitiers University Hospital, as stated by NIH Gov., evaluated 1,456 cancer patients with the help of next-generation sequencing and found that 835 actionable mutations were identified, with the most common mutations being those of KRAS (43.6%), BRAF (19.0%), and PIK3CA (10.8%), as per the details provided by NIH Gov.
Furthermore, the results of the study indicated that through the application of larger genomic panels named FoundationOne CDx, the identification of actionable mutations increased from 34.0% to 64.0%, along with the percentage of identifying eligible candidates for clinical trials increasing from 12.0% to 16.0%. This growing adoption of NGS strengthens its role in advancing precise genomic screening and embryo risk assessment.
IVF Genetic Risk Scoring Market- Geographical Insights
Asia Pacific is projected to hold key place in the market due to increased development of fertility infrastructure, growing awareness of genetic disorders, and favourable government policies. For example, in December 2025, as per the Japan Society of Obstetrics and Gynecology (JSOG) NIH Gov. report, there are 638 registered facilities for ART in Japan, out of which 625 (98.0%) are registered in the registry, and 610 facilities provide ART treatment. They provided 561,664 ART treatment cycles with a 3.3% increase rate, while the neonates were 85,048 with a 10.2% increase as compared to last year. The report indicated that 276,153 FET cycles were done, with a 4.4% increase, whereas 205,986 (36.7%) of the cycles had the women aged 40 years and above. The development in fertility infrastructure could be assessed by the level of treatment being performed across the region, in which there were 281,665 fresh cycles with oocyte retrieval, out of which 168,343 (59.8%) were freeze-all cycles, and 85,048 neonates were born through ART. This expansion of ART infrastructure strengthens Asia Pacific’s position as a leading regional market.
IVF Genetic Risk Scoring Market- Competitive Landscape:
Key players in the IVF Genetic Risk Scoring market are focusing on developing new technologies and healthcare services in the field of genetic testing and reproductive health, which include such companies as Illumina, Inc.; Natera, Inc.; Agilent Technologies, Inc.; CooperSurgical, Inc.; and Thermo Fisher Scientific, Inc. Main companies are trying to retain their position in the market by innovating and providing new technologies and solutions related to genetic screening and IVF. Main players are spending their R&D expenditures to improve their capacities and expand their product portfolio in order to retain their leadership in the market. In December 2025, Illumina announces a collaboration with MyOme to incorporate its sequencing technologies in combination with the latter’s polygenic risk models for several types of diseases, including cancer, cardiometabolic, kidney, liver, and cognitive diseases. This partnership is important for the genetic-risk scoring market, as it combines genome-wide sequencing with polygenic risk analysis.
Recent Developments:
- In December 2025, Natera acquired Foresight Diagnostics for $424.5 million in order to expand its genomic testing portfolio, which would incorporate the ctDNA technology of Foresight Diagnostics. However, the acquisition is relevant for oncology and minimal residual disease testing but not for IVF genetic risk score testing. Therefore, the acquisition is relevant to the market indirectly.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IVF GENETIC RISK SCORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Genomic Prediction (LifeView)
- Orchid Health
- MyOme
- Herasight
- Natera, Inc.
- CooperSurgical, Inc.
- Vitrolife AB
- Igenomix
- Juno Genetics
- Invicta Genetics
- Bioarray S.L.
- Reproductive Health Science Ltd.
- Genesis Genetics
- Genea Limited
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- Polygenic Risk Scoring
- Whole Genome Sequencing
- Carrier Screening Panels
- Single-Gene Risk Scoring
GLOBAL IVF GENETIC RISK SCORING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- PCR-Based Methods
- AI & Machine Learning Algorithms
- Microarray
- NGS (Next-Generation Sequencing)
GLOBAL IVF GENETIC RISK SCORING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Personalized IVF Protocols
- Disease Risk Prediction
- Embryo Selection
- Trait Screening
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutes
- Genetic Counseling Firms
- IVF Centers
- Fertility Clinics
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. IVF Genetic Risk Scoring Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. IVF Genetic Risk Scoring Key Market Trends
3.1. IVF Genetic Risk Scoring Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. IVF Genetic Risk Scoring Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. IVF Genetic Risk Scoring Market Opportunities
3.4. IVF Genetic Risk Scoring Market Future Trends
4. IVF Genetic Risk Scoring Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. IVF Genetic Risk Scoring Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. IVF Genetic Risk Scoring Market Landscape
6.1. IVF Genetic Risk Scoring Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. IVF Genetic Risk Scoring Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
7.1.2. Polygenic Risk Scoring
7.1.3. Whole Genome Sequencing
7.1.4. Carrier Screening Panels
7.1.5. Single-Gene Risk Scoring
8. IVF Genetic Risk Scoring Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. PCR-Based Methods
8.1.3. AI & Machine Learning Algorithms
8.1.4. Microarray
8.1.5. NGS (Next-Generation Sequencing)
9. IVF Genetic Risk Scoring Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Personalized IVF Protocols
9.1.3. Disease Risk Prediction
9.1.4. Embryo Selection
9.1.5. Trait Screening
9.1.6. Others
10. IVF Genetic Risk Scoring Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Research Institutes
10.1.3. Genetic Counseling Firms
10.1.4. IVF Centers
10.1.5. Fertility Clinics
10.1.6. Others
11. IVF Genetic Risk Scoring Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. IVF Genetic Risk Scoring Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. IVF Genetic Risk Scoring Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Denmark Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. IVF Genetic Risk Scoring Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. IVF Genetic Risk Scoring Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. IVF Genetic Risk Scoring Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- IVF Genetic Risk Scoring Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Genomic Prediction (LifeView)
12.2.2. Orchid Health
12.2.3. MyOme
12.2.4. Herasight
12.2.5. Natera, Inc.
12.2.6. CooperSurgical, Inc.
12.2.7. Vitrolife AB
12.2.8. Igenomix
12.2.9. Juno Genetics
12.2.10. Invicta Genetics
12.2.11. Bioarray S.L.
12.2.12. Reproductive Health Science Ltd.
12.2.13. Genesis Genetics
12.2.14. Genea Limited
12.2.15. Illumina, Inc.
12.2.16. Thermo Fisher Scientific, Inc.
12.2.17. Agilent Technologies, Inc.
12.2.18. Quest Diagnostics Incorporated
12.2.19. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IVF GENETIC RISK SCORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Genomic Prediction (LifeView)
- Orchid Health
- MyOme
- Herasight
- Natera, Inc.
- CooperSurgical, Inc.
- Vitrolife AB
- Igenomix
- Juno Genetics
- Invicta Genetics
- Bioarray S.L.
- Reproductive Health Science Ltd.
- Genesis Genetics
- Genea Limited
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- Polygenic Risk Scoring
- Whole Genome Sequencing
- Carrier Screening Panels
- Single-Gene Risk Scoring
GLOBAL IVF GENETIC RISK SCORING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- PCR-Based Methods
- AI & Machine Learning Algorithms
- Microarray
- NGS (Next-Generation Sequencing)
GLOBAL IVF GENETIC RISK SCORING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Personalized IVF Protocols
- Disease Risk Prediction
- Embryo Selection
- Trait Screening
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutes
- Genetic Counseling Firms
- IVF Centers
- Fertility Clinics
- Others
GLOBAL IVF GENETIC RISK SCORING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
